Rapid diagnosis is
a critical aspect associated with controlling
the spread of COVID-19. Electrochemical sensor platforms are ideally
suited for rapid and highly sensitive detection of biomolecules. This
review focuses on state-of-the-art of COVID-19 biomarker detection
by utilizing electrochemical biosensing platforms. Point-of-care (POC)
sensing is one of the most promising and emerging fields in detecting
and quantifying health biomarkers. Electrochemical biosensors play
a major role in the development of point-of-care devices because of
their high sensitivity, specificity, and ability for rapid analysis.
Integration of electrochemistry with point-of-care technologies in
the context of COVID-19 diagnosis and screening has facilitated in
convenient
operation, miniaturization, and portability. Identification of potential
biomarkers in disease diagnosis is crucial for patient monitoring
concerning severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
In this review, we will discuss the choice of biomarkers in addition
to the various types of electrochemical sensors that have been developed
to meet the needs of rapid detection and disease severity analysis.